1. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS.Relationship between serum copper, ceruloplasmin, and nonceruloplasmin-bound copper in routine clinical practice. Clin Chem2005;51:1558-9. [DOI via Crossref] [Pubmed] |
|
2. Winston GP, Jaiser SR. Copper deficiency: An unusual case ofmyelopathy with neuropathy. Ann Clin Biochem 2008;45:616-7. [DOI via Crossref] [Pubmed] |
|
3. Shimizu H, Kiyohara Y, Kato I, Kitazono T, Tanizaki Y, Kubo M, et al.Relationship between plasma glutathione levels and cardiovasculardisease in a defined population: The Hisayama study. Stroke2004;35:2072-7. [DOI via Crossref] [Pubmed] |
|
4. Peter K, Lip GY. Thrombosis and cardiovascular disease: Excitingperspectives in cardiovascular prevention and therapy. ThrombHaemost 2010;103:875-6. [DOI via Crossref] [Pubmed] |
|
5. Zhang W, Sun K, Chen J, Liao Y, Qin Q, Ma A, et al. High plasmahomocysteine levels contribute to the risk of stroke recurrence andall-cause mortality in a large prospective stroke population. Clin Sci(Lond) 2009;118:187-94. [DOI via Crossref] [Pubmed] |
|
6. Gil-Prieto R, Hernández V, Cano B, Oya M, Gil A. Plasmahomocysteine in adolescents depends on the interaction betweenmethylenetetrahydrofolate reductase genotype, lipids and folate: Aseroepidemiological study. Nutr Metab (Lond) 2009;6:39. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
7. Study of the Effectiveness of Additional Reductions in Cholesteroland Homocysteine (SEARCH) Collaborative Group, Armitage JM,Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, et al. Effects ofhomocysteine-lowering with folic acid plus vitamin B12 vs placeboon mortality and major morbidity in myocardial infarction survivors:A randomized trial. JAMA 2010;303:2486-94. [DOI via Crossref] [Pubmed] |
|
8. NRC. Nutrient Requirements of Laboratory Animals. 4th ed.Washington, DC: National Academies Press; 1995. p. 11-79. |
|
9. AOAC. Official Methods of Analysis. 17th ed. Arlington, VA:Association of Official Analytical Chemists; 2000. |
|
10. Abell LL, Levy BB, Brodie BB, Kendal FE. Determination of cholesterol.Stand Methods Clin Chem 1958;2:26-9. [DOI via Crossref] |
|
11. Rice EW. Determination of triglycerides by a colourimetric method.In: MacDonald RP, editor. Standard Methods of Clinical Chemistry.New York: Academic Press; 1970. p. 215-7. |
|
12. Ishikawa TT, Brazier JB, Steiner PM, Stewart LE, Gartside PS,Glueck CJ. A study of the heparin-manganese chloride method fordetermination of plasma alpha-lipoprotein cholesterol concentration.Lipids 1976;11:628-33. [DOI via Crossref] [Pubmed] |
|
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of theconcentration of low-density lipoprotein cholesterol in plasma,without use of the preparative ultracentrifuge. Clin Chem1972;18:499-502. [Pubmed] |
|
14. Griffith OW. Determination of glutathione and glutathione disulfideusing glutathione reductase and 2-vinylpyridine. Anal Biochem1980;106:207-12. [DOI via Crossref] |
|
15. Watanabe M. Flameless atomic absorption spectrometry for analysis oftrace elements in biological materials. Nihon Rinsho 1996;54:228-32. [Pubmed] |
|
16. Frantzen F, Faaren AL, Alfheim I, Nordhei AK. Enzyme conversionimmunoassay for determining total homocysteine in plasma orserum. Clin Chem 1998;44:311-6. [Pubmed] |
|
17. Boyden R, Potter VR, Elvehjem CA. Effect of feeding high levels ofcopper to albino rats. J Nutr 1938;15:397-402. |
|
18. Reiser S, Ferretti RJ, Fields M, Smith JC Jr. Role of dietary fructose inthe enhancement of mortality and biochemical changes associatedwith copper deficiency in rats. Am J Clin Nutr 1983;38:214-22. [Pubmed] |
|
19. al-Othman AA, Rosenstein F, Lei KY. Copper deficiency alters plasmapool size, percent composition and concentration of lipoproteincomponents in rats. J Nutr 1992;122:1199-204. [Pubmed] |
|
20. Mazur A, Nassir F, Gueux E, Cardot P, Bellanger J, Lamand M, et al.The effect of dietary copper on rat plasma apolipoprotein B, E plasmalevels, and apolipoprotein gene expression in liver and intestine. BiolTrace Elem Res 1992;34:107-13. [DOI via Crossref] [Pubmed] |
|
21. Shao MJ, Lei KY. Conversion of [2-14C] mevalonate intocholesterol, lanosterol and squalene in copper-deficient rats. J Nutr1980;110:859-67. [Pubmed] |
|
22. Allen KG, Klevay LM. Cholesterol metabolism in copper deficientrats. Life Sci 1978;22:1691-7. [DOI via Crossref] |
|
23. Yount NY, Carr TP, McNamara DJ, Lei KY. Incorporation of tritiatedwater into sterol in copper-deficient rats. Biochim Biophys Acta1991;1082:79-84. [DOI via Crossref] |
|
24. Lefevre M, Keen CL, Lönnerdal B, Hurley LS, Schneeman BO. Differenteffects of zinc and copper deficiency on composition of plasma highdensity lipoproteins in rats. J Nutr 1985;115:359-68. [Pubmed] |
|
25. Witztum J, Schonfeld G. High density lipoproteins. Diabetes1979;28:326-33. [DOI via Crossref] [Pubmed] |
|
26. Uthus EO, Reeves PG, Saari JT. Copper deficiency decreases plasmahomocysteine in rats. J Nutr 2007;137:1370-4. [Pubmed] |
|
27. Bunce GE. Hypercholesterolemia of copper deficiency is linkedto glutathione metabolism and regulation of hepatic HMG-CoAreductase. Nutr Rev 1993;51:305-7. [DOI via Crossref] [Pubmed] |
|
28. Roitelman J, Shechter I. Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase. Evidence for thiol-dependentallosteric modulation of enzyme activity. J Biol Chem 1984;259:870-7. [Pubmed] |
|
29. Megahed AM. Effect of dietary copper deficiency on liver lipidsand antioxidant defense system in rats. Bull High Inst Public Health1998;28:207-14. |
|
30. Mosharov E, Cranford MR, Banerjee R. The quantitatively importantrelationship between homocysteine metabolism and glutathionesynthesis by the transsulfuration pathway and its regulation by redoxchanges. Biochemistry 2000;39:13005-11. [DOI via Crossref] [Pubmed] |
|
31. Kang YJ. Copper and homocysteine in cardiovascular diseases.Pharmacol Ther 2011;129:321-31. [DOI via Crossref] [Pubmed] |
|